Most people with cancer who are infected by the novel coronavirus produce antibodies at a rate comparable to the rest
Majority of cancer patients with COVID-19 have similar immune response to people without cancer
VHIO-born spin-off receives approval to initiate Phase I/II clinical trial of novel Myc inhibitor
Co-founded back in 2014 by VHIO's Laura Soucek, CEO of the enterprise, and Marie-Eve Beaulieu, Chief Scientific Officer (CSO) of
Cancer trial participation does not eliminate disparities for poor patients
Even with access to a clinical trial, cancer patients living in the poorest neighborhoods in America have a nearly 30
Cognitive behavioral therapy can reduce dental anxiety in children
A pioneering study led by the University of Sheffield and Sheffield Teaching Hospitals will investigate whether Cognitive Behavioral Therapy (CBT)
Cancer ‘guardian’ breaks bad with one switch
A mutation that replaces a single amino acid in a potent tumor-suppressing protein turns it from saint to sinister. A
Breast Cancer Mortality in Under 40s Resparks Screening Debate
In the United States, breast cancer mortality rates dropped every year for women across all age groups between 1989 and
Origin of childhood cancer malignant rhabdoid tumour discovered
The first proof of the origin of malignant rhabdoid tumor (MRT), a rare childhood cancer, has been discovered by researchers
Lack of Skin Biopsy Equipment Could Mean Delayed Diagnosis
NEW YORK (Reuters Health) – Low-income countries that lack the necessary equipment for skin biopsies may not be able to
Seven ways alcohol affects the body – including damaging immune system
We all like a drink from time to time, for fun or relaxation, but it doesn’t take much of it
Clinical trial shows five-year outcomes of CAR T-cell therapy for non-Hodgkin lymphomas
A significant number of non-Hodgkin lymphoma (NHL) patients in a Penn Medicine-initiated clinical trial continue to be in remission five